New Prescription Option for Fibromyalgia Treatment
Patients with fibromyalgia have waited more than a decade for a new therapeutic option, and a recent regulatory approval signals… More Details
Stay connected to the latest clinical updates, teaching strategies, and practice-ready skills – delivered in a format that fits your busy life. Learn on your schedule without sacrificing quality or depth.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update Series is included with your Pharmacist Subscription. But wait…there’s even more!
What the Pharmacist CE Subscription Includes:
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
Patients with fibromyalgia have waited more than a decade for a new therapeutic option, and a recent regulatory approval signals… More Details
Pain relief medications like acetaminophen and ibuprofen are staples in everyday care—but emerging research suggests they may play a role… More Details
Recent FDA actions have brought renewed attention to leucovorin as a potential treatment for managing symptoms associated with autism spectrum… More Details
Pharmacists play a critical role in infectious disease care, and staying up to date on antibiotic therapies is key to… More Details
Discover the benefits of implementing a long-acting injectable (LAI) service at your pharmacy practice site and the impact this service… More Details
Discover the benefits of implementing a long-acting injectable (LAI) service at your pharmacy practice site and the impact this service… More Details
Opioids remain a cornerstone of palliative care for patients with serious illnesses like cancer, yet their use is often misunderstood,… More Details
Respiratory syncytial virus (RSV) continues to pose a serious health threat—particularly to infants, older adults, and immunocompromised individuals—making it critical… More Details
GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a… More Details
GLP-1 receptor agonists have revolutionized the treatment of diabetes and obesity, but recent data suggest a potential link to a… More Details
Heart failure remains a leading cause of hospitalization, prompting ongoing research into treatment strategies that improve outcomes for patients. A… More Details
Heart failure remains a leading cause of hospitalization, prompting ongoing research into treatment strategies that improve outcomes for patients. A… More Details